Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vargatef added to first-line chemotherapy with interval debulking surgery in advanced ovarian, fallopian tube, or primary peritoneal adenocarcinoma
2011-006288-23Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nintedanib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by ARCAGY. Started Sep 2012; status: completed.
02
Drugs
nintedanib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on 2011-006288-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006288-23.